227 related articles for article (PubMed ID: 15264184)
1. A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers.
Wu G; Wadgymar A; Wong G; Ting R; Nathoo B; Mendelssohn D; Pandeya S; Sapir D; Tam P
Am J Kidney Dis; 2004 Aug; 44(2):264-9. PubMed ID: 15264184
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient.
Shingu Y; Nakata T; Sawai S; Tanaka H; Asai O; Tamagaki K; Nakatani K
BMC Nephrol; 2020 Jul; 21(1):275. PubMed ID: 32664894
[TBL] [Abstract][Full Text] [Related]
3. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).
Macdougall IC; Casadevall N; Locatelli F; Combe C; London GM; Di Paolo S; Kribben A; Fliser D; Messner H; McNeil J; Stevens P; Santoro A; De Francisco AL; Percheson P; Potamianou A; Foucher A; Fife D; Mérit V; Vercammen E;
Nephrol Dial Transplant; 2015 Mar; 30(3):451-60. PubMed ID: 25239637
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA
Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586
[TBL] [Abstract][Full Text] [Related]
6. Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients.
Kharagjitsingh AV; Korevaar JC; Vandenbroucke JP; Boeschoten EW; Krediet RT; Daha MR; Dekker FW;
Kidney Int; 2005 Sep; 68(3):1215-22. PubMed ID: 16105053
[TBL] [Abstract][Full Text] [Related]
7. Pure red-cell aplasia caused by the antibody to recombinant erythropoietin, epoetin-beta, in a Japanese patient with chronic renal failure.
Shinohara K; Mitani N; Miyazaki M; Sakuragi S; Matsuda K; Ogawara S; Saito T; Kaneoka H; Ooji T
Am J Hematol; 2005 Jan; 78(1):15-20. PubMed ID: 15609276
[TBL] [Abstract][Full Text] [Related]
8. Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis.
Asari A; Gokal R
J Am Soc Nephrol; 2004 Aug; 15(8):2204-7. PubMed ID: 15284306
[TBL] [Abstract][Full Text] [Related]
9. Pure red cell aplasia and anti-erythropoietin antibodies in patients on hemodialysis: a report of two cases and a literature review.
Lacreta G; Bucharles SGE; Sevignani G; Riella MC; Nascimento MMD
J Bras Nefrol; 2019; 41(1):145-151. PubMed ID: 30160771
[TBL] [Abstract][Full Text] [Related]
10. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
[TBL] [Abstract][Full Text] [Related]
12. Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.
Mattison P; Upadhyay K; Wilcox JE; Moudgil A; Silverstein DM
Pediatr Nephrol; 2010 May; 25(5):971-6. PubMed ID: 20091055
[TBL] [Abstract][Full Text] [Related]
13. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another.
Macdougall IC
Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076
[TBL] [Abstract][Full Text] [Related]
14. Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies.
Fraer M; Campbell A; Sawaya BP
Semin Dial; 2006; 19(3):251-4. PubMed ID: 16689978
[TBL] [Abstract][Full Text] [Related]
15. Epoetin-associated pure red cell aplasia: past, present, and future considerations.
McKoy JM; Stonecash RE; Cournoyer D; Rossert J; Nissenson AR; Raisch DW; Casadevall N; Bennett CL
Transfusion; 2008 Aug; 48(8):1754-62. PubMed ID: 18482185
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy.
Chng WJ; Tan LK; Liu TC
Am J Kidney Dis; 2003 Mar; 41(3):692-5. PubMed ID: 12612995
[TBL] [Abstract][Full Text] [Related]
17. Epoetin-induced autoimmune pure red cell aplasia.
Casadevall N
Hematol J; 2004; 5 Suppl 3():S104-9. PubMed ID: 15190289
[No Abstract] [Full Text] [Related]
18. Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.
Casadevall N
Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii37-41. PubMed ID: 14608000
[TBL] [Abstract][Full Text] [Related]
19. Antiepoetin antibody-related pure red cell aplasia: successful remission with cessation of recombinant erythropoietin alone.
Katagiri D; Shibata M; Katsuki T; Masumoto S; Katsuma A; Minami E; Hoshino T; Inoue T; Tada M; Hinoshita F
Clin Exp Nephrol; 2010 Oct; 14(5):501-5. PubMed ID: 20652821
[TBL] [Abstract][Full Text] [Related]
20. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
Janda K; Kraśniak A; Krzanowski M; Sułowicz W
Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
